Title : Phosphatidyl Inositol 3 kinases inhibitor development using novel invitro pharmacological assays

Type of Material: Thesis
Title: Phosphatidyl Inositol 3 kinases inhibitor development using novel invitro pharmacological assays
Researcher: Mahesh Yanamandra
Guide: Sayan Mitra
Archana Giri
Department: Faculty of Biotechnology
Publisher: Jawaharlal Nehru Technological University, Hyderabad
Place: Hyderabad
Year: 2015
Language: English
Subject: Biotechnology and Applied Microbiology
Life Sciences
Microbiology
Biotechnology
Engineering and Technology
Dissertation/Thesis Note: PhD; Faculty of Biotechnology, Jawaharlal Nehru Technological University, Hyderabad, Hyderabad; 2015
Fulltext: Shodhganga

00000000ntm a2200000ua 4500
001454232
003IN-AhILN
0052024-07-29 17:30:51
008__240729t2015||||ii#||||g|m||||||||||eng||
035__|a(IN-AhILN)th_454232
040__|aJNTU_500028|dIN-AhILN
041__|aeng
100__|aMahesh Yanamandra|eResearcher
110__|aFaculty of Biotechnology|bJawaharlal Nehru Technological University, Hyderabad|dHyderabad|ein|0U-0017
245__|aPhosphatidyl Inositol 3 kinases inhibitor development using novel invitro pharmacological assays
260__|aHyderabad|bJawaharlal Nehru Technological University, Hyderabad|c2015
300__|a197p.|dDVD
502__|cFaculty of Biotechnology, Jawaharlal Nehru Technological University, Hyderabad, Hyderabad|d2015|bPhD
518__|dSeptember 2015|oDate of Award
518__|oDate of Registration|d2010-01-01
520__|aThe phosphatidyl inositol 3-kinases(PI3Ks) are lipid kinases that regulate the newlinecellular signal transduction pathways involved in cell growth, proliferation, newlinesurvival, apoptosis and adhesion. Deregulations of these pathways are common newlinein oncogenesis and are known to be altered in other metabolic disorders as well. In spite of its huge potential as an attractive target in the above diseases, newlinethere is an unmet need for the development of a successful inhibitor. Unlike protein kinase inhibitor, screening for lipid kinase inhibitor has been challenging due to the lipidic nature of PI3K substrates known as phosphoinositides. Here we report for the first time, the development of unique and novel radioactive lipid kinase screening platform using phosphocellulose newlinepaper that involves transfer of adiolabelled [?P32] ATP to phosphatidylinositol 4,5 phosphate forming Phosphatidylinositol-3,4,5 phosphate captured on the phosphocellulose matrix. Enzyme kinetics and inhibitory properties
650__|aBiotechnology|2UGC
650__|aEngineering and Technology|2AIU
653__|aBiotechnology and Applied Microbiology
653__|aLife Sciences
653__|aMicrobiology
700__|aSayan Mitra|eGuide
700__|eCo-Guide|aArchana Giri
856__|uhttp://shodhganga.inflibnet.ac.in/handle/10603/291073|yShodhganga
905__|afromsg

User Feedback Comes Under This section.